Medicenna Therapeutics Corp.(Toronto Stock Exchange : MDNA)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.62% | 199.19 | 0.0% | $1686.05m | |
| BIIB | Biogen, Inc. | 1.28% | 388.44 | 1.7% | $1298.22m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 5.98% | 12.76 | 0.7% | $891.97m | |
| NVAX | Novavax, Inc. | -3.05% | 174.41 | 79.8% | $677.69m | |
| AMGN | Amgen, Inc. | -0.86% | 238.68 | 1.3% | $653.84m | |
| BNTX | BioNTech SE | -0.83% | 212.42 | 0.0% | $524.93m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.27% | 187.85 | 1.9% | $517.31m | |
| GILD | Gilead Sciences, Inc. | -0.91% | 66.61 | 1.0% | $493.35m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.36% | 537.92 | 2.7% | $384.81m | |
| ILMN | Illumina, Inc. | 0.18% | 456.16 | 3.5% | $365.16m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.40% | 180.69 | 2.0% | $338.92m | |
| OCGN | Ocugen, Inc. | 0.00% | 6.54 | 0.0% | $285.39m | |
| EXAS | EXACT Sciences Corp. | -0.30% | 126.52 | 18.1% | $189.07m | |
| TXG | 10X Genomics, Inc. | -2.18% | 194.43 | 0.0% | $173.74m | |
| BNGO | Bionano Genomics, Inc. | -3.05% | 7.62 | 0.0% | $165.33m |
Company Profile
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.